Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biostage (BSTG)
OTHER OTC:BSTG
Biostage (BSTG) Stock Price & Analysis
0 Followers
BSTG Stock Chart & Stats
Day’s Range$4 - $4.14
52-Week Range― - ―
Previous Close$4
Volume4.53K
Average Volume (3M)N/A
Market Cap
$58.24M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding13,882,060
10 Day Avg. Volume1,858
30 Day Avg. Volume1,295
Standard Deviation0.26
R-Squared0.05
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)-50.59
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-13.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Biostage News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BSTG FAQ
What was Biostage’s price range in the past 12 months?
Currently, no data Available
What is Biostage’s market cap?
Currently, no data Available
When is Biostage’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Biostage’s earnings last quarter?
Currently, no data Available
Is Biostage overvalued?
According to Wall Street analysts Biostage’s price is currently Overvalued.
Does Biostage pay dividends?
Biostage does not currently pay dividends.
What is Biostage’s EPS estimate?
Biostage’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biostage have?
Currently, no data Available
What happened to Biostage’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Biostage?
Currently, no hedge funds are holding shares in BSTG
---
Biostage Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
Biostage
Biostage, Inc. is a biotechnology company, which engages in the development of organ implants to treat congenital defects, cancers, and life-threatening conditions of the esophagus, bronchus and trachea. It operates through Cellframe technology, engineered to stimulate the body's signaling pathways and natural healing process to regenerate and restore organ function. The company was founded on May 3, 2012 and is headquartered in Holliston, MA.
---
Technical Analysis
---